We use our proprietary models to rate both quantitatively and qualitatively, and select the top 10 names from an initial list ...
Baxter trades at low valuations with 8x forward cash earnings, debt reduction, cost controls, margin expansion, and $50 2027 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback